Smart Patients Get Smart Care™

The World’s Leading Authority for Chronic Lymphocytic Leukemia Patients

CLL Society Letter Writing Campaign to Congress: Please Consider the Immunocompromised When Making COVID-19 Decisions

In science and medicine, information is constantly changing and may become out-of-date as new data emerge. All articles and interviews are informational only, should never be considered medical advice, and should never be acted on without review with your health care team.

From May through July of 2022, CLL Society organized a grassroots letter-writing campaign engaging the powerful voices of our community. Nearly 1,000 letters were sent to elected members of Congress reminding them that those with CLL/SLL are part of the estimated seven million immunocompromised Americans, and these individuals continue to be at higher risk for poor outcomes should they become infected with COVID-19.

This advocacy effort was to remind Congress about the importance of giving proper attention to the ongoing needs of the immunocompromised as future decisions are being made, including when considering any future funding to cover the costs of testing, vaccinations, and life-saving COVID-19 treatments.

CLL Society believes that with the emergence of each new COVID-19 variant of concern, our elected government officials must have a long-term strategy in mind when it comes to anticipating the country’s ongoing needs related to COVID-19 preventative therapies and treatments.

CLL Society would like to extend our gratitude to each of you who engaged in this critical campaign.

RECENT NEWS

When appropriate, the CLL Society will be posting updates and background information on the present Coronavirus pandemic focusing on reliable primary sources of information and avoiding most of the news that is not directly from reliable medical experts or government and world health agencies.